NCT04025879 · BASELINE

Baseline characteristics

A Study of Neoadjuvant Chemotherapy Plus Nivolumab Versus Neoadjuvant Chemotherapy Plus Placebo, Followed by Surgical Removal and Adjuvant Treatment With Nivolumab or Placebo for Participants With Surgically Removable Early Stage Non-small Cell Lung Cancer · Source last updated 2026-08-26

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms

counts
group Id
BG000
value
229
group Id
BG001
value
232
group Id
BG002
value
461
units
Participants

groups

description
Nivolumab 360 mg Q3W + SOC platinum-based doublet chemotherapy Q3W x 4 cycles as neoadjuvant treatment followed by surgery; then post surgery nivolumab 480 mg Q4W adjuvant treatment for up to 13 cycles (approximately 1 year)
id
BG000
title
Nivolumab + SOC Chemotherapy
description
Placebo Q3W + SOC platinum-based doublet chemotherapy Q3W x 4 cycles as neoadjuvant treatment followed by surgery, then post-surgery placebo Q4W for up to 13 cycles (approximately 1 year).
id
BG001
title
Placebo + SOC Chemotherapy
description
Total of all reporting groups
id
BG002
title
Total

measures

classes
categories
measurements
group Id
BG000
value
0
group Id
BG001
value
0
group Id
BG002
value
0
title
<=18 years
measurements
group Id
BG000
value
102
group Id
BG001
value
100
group Id
BG002
value
202
title
Between 18 and 65 years
measurements
group Id
BG000
value
127
group Id
BG001
value
132
group Id
BG002
value
259
title
>=65 years
param Type
COUNT_OF_PARTICIPANTS
title
Age, Categorical
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
spread
7.9
value
64.2
group Id
BG001
spread
8.4
value
64.6
group Id
BG002
spread
8.1
value
64.4
dispersion Type
STANDARD_DEVIATION
param Type
MEAN
title
Age, Continuous
unit Of Measure
Years
classes
categories
measurements
group Id
BG000
value
62
group Id
BG001
value
72
group Id
BG002
value
134
title
Female
measurements
group Id
BG000
value
167
group Id
BG001
value
160
group Id
BG002
value
327
title
Male
param Type
COUNT_OF_PARTICIPANTS
title
Sex: Female, Male
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
9
group Id
BG001
value
17
group Id
BG002
value
26
title
Hispanic or Latino
measurements
group Id
BG000
value
128
group Id
BG001
value
113
group Id
BG002
value
241
title
Not Hispanic or Latino
measurements
group Id
BG000
value
92
group Id
BG001
value
102
group Id
BG002
value
194
title
Unknown or Not Reported
param Type
COUNT_OF_PARTICIPANTS
title
Ethnicity (NIH/OMB)
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
0
group Id
BG001
value
0
group Id
BG002
value
0
title
American Indian or Alaska Native
measurements
group Id
BG000
value
66
group Id
BG001
value
50
group Id
BG002
value
116
title
Asian
measurements
group Id
BG000
value
0
group Id
BG001
value
0
group Id
BG002
value
0
title
Native Hawaiian or Other Pacific Islander
measurements
group Id
BG000
value
4
group Id
BG001
value
4
group Id
BG002
value
8
title
Black or African American
measurements
group Id
BG000
value
155
group Id
BG001
value
175
group Id
BG002
value
330
title
White
measurements
group Id
BG000
value
0
group Id
BG001
value
0
group Id
BG002
value
0
title
More than one race
measurements
group Id
BG000
value
4
group Id
BG001
value
3
group Id
BG002
value
7
title
Unknown or Not Reported
param Type
COUNT_OF_PARTICIPANTS
title
Race (NIH/OMB)
unit Of Measure
Participants

Complete source fields

denoms

counts
group Id
BG000
value
229
group Id
BG001
value
232
group Id
BG002
value
461
units
Participants

groups

description
Nivolumab 360 mg Q3W + SOC platinum-based doublet chemotherapy Q3W x 4 cycles as neoadjuvant treatment followed by surgery; then post surgery nivolumab 480 mg Q4W adjuvant treatment for up to 13 cycles (approximately 1 year)
id
BG000
title
Nivolumab + SOC Chemotherapy
description
Placebo Q3W + SOC platinum-based doublet chemotherapy Q3W x 4 cycles as neoadjuvant treatment followed by surgery, then post-surgery placebo Q4W for up to 13 cycles (approximately 1 year).
id
BG001
title
Placebo + SOC Chemotherapy
description
Total of all reporting groups
id
BG002
title
Total

measures

classes
categories
measurements
group Id
BG000
value
0
group Id
BG001
value
0
group Id
BG002
value
0
title
<=18 years
measurements
group Id
BG000
value
102
group Id
BG001
value
100
group Id
BG002
value
202
title
Between 18 and 65 years
measurements
group Id
BG000
value
127
group Id
BG001
value
132
group Id
BG002
value
259
title
>=65 years
param Type
COUNT_OF_PARTICIPANTS
title
Age, Categorical
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
spread
7.9
value
64.2
group Id
BG001
spread
8.4
value
64.6
group Id
BG002
spread
8.1
value
64.4
dispersion Type
STANDARD_DEVIATION
param Type
MEAN
title
Age, Continuous
unit Of Measure
Years
classes
categories
measurements
group Id
BG000
value
62
group Id
BG001
value
72
group Id
BG002
value
134
title
Female
measurements
group Id
BG000
value
167
group Id
BG001
value
160
group Id
BG002
value
327
title
Male
param Type
COUNT_OF_PARTICIPANTS
title
Sex: Female, Male
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
9
group Id
BG001
value
17
group Id
BG002
value
26
title
Hispanic or Latino
measurements
group Id
BG000
value
128
group Id
BG001
value
113
group Id
BG002
value
241
title
Not Hispanic or Latino
measurements
group Id
BG000
value
92
group Id
BG001
value
102
group Id
BG002
value
194
title
Unknown or Not Reported
param Type
COUNT_OF_PARTICIPANTS
title
Ethnicity (NIH/OMB)
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
0
group Id
BG001
value
0
group Id
BG002
value
0
title
American Indian or Alaska Native
measurements
group Id
BG000
value
66
group Id
BG001
value
50
group Id
BG002
value
116
title
Asian
measurements
group Id
BG000
value
0
group Id
BG001
value
0
group Id
BG002
value
0
title
Native Hawaiian or Other Pacific Islander
measurements
group Id
BG000
value
4
group Id
BG001
value
4
group Id
BG002
value
8
title
Black or African American
measurements
group Id
BG000
value
155
group Id
BG001
value
175
group Id
BG002
value
330
title
White
measurements
group Id
BG000
value
0
group Id
BG001
value
0
group Id
BG002
value
0
title
More than one race
measurements
group Id
BG000
value
4
group Id
BG001
value
3
group Id
BG002
value
7
title
Unknown or Not Reported
param Type
COUNT_OF_PARTICIPANTS
title
Race (NIH/OMB)
unit Of Measure
Participants

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice